Every drug or device development project is like climbing Mount Everest for the very first time; you need experienced mountaineers to prepare and guide you to the apex. Novateur team is ready to be your guide on your expedition.

The best blockbuster movie comes together by coupling the best script with the "perfect actors, directors, and production experts". Drug and device development also requires the perfect team with the relevant and recent experience & success. Novateur casts the right team for your vision.

In the world of global drug or device development, "only the best teams" can ensure success. Novateur assembles the best global teams to ensure you reach your goals.



"I have made it my life-long mission to ensure promising life science inventions get access to the best possible advice, are developed properly and reach patients worldwide."

Ali Ardakani

Founder & Managing Director

“We integrate a variety of disciplines that require an analytical, detail-oriented mind but also the big picture perspective and a feel for people."

Anne Assmus, PhD

Head of Global Business Development, Oncology & Immuno-Oncology

“Our practical IP advice helps you secure your innovations and attract investors and corporate partners.”

Thomas Digby, JD

Global IP Lead

“We source the facts and deal with the "hard-core" science, leaving sensationalized hype behind.”

Colin Funk, PhD

Scientific Lead

"We develop a narrative and design a business development plan that faithfully translates technical Research & Development into differentiated benefits for patients, investors and society."

David Kennard, MBA, PhD, MRPHARMS

Senior Advisor, Business Development Therapeutics


Our clinical translation and business development experts are fine-tuned to specific programs and needs, ensuring your success.

what our clients say

Every interaction with our clients needs to create value for them and potential future patients.

Innovative Targeting Solutions

Innovative Targeting Solutions retained the Novateur development and commercial team to analyze and vet several of their products candidates in (...)

Michael L. Gallo, PhD
President, Innovative Targeting Solutions

Beyond Air

Beyond’s Air engagement with Novateur Ventures began in 2015 (when Beyond Air was known as AIT Therapeutics). Novateur was engaged (...)

Amir Avniel
Co-Founder, COO & President, Beyond Air

Navigo Proteins GmbH

Navigo Proteins retained Novateur’s expert to evaluate its platform and advise on the best possible Target Product Profiles in the (...)

Dr. Henning Afflerbach
Managing Director, Navigo Proteins


Subscribe to our newsletter for access to latest updates.


Access Novateur news as well as FDA and Expert Databases.


Check out conferences and events we are attending!


Read articles by our team! Featured in BioteCanada Insights and Nature among others.